Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer

Breast Cancer

Volumn 9, Issue 1, 2002, Pages 20-25

  Inaji, Hideo ^a   Komoike, Yoshifumi ^a   Motomura, Kazuyoshi ^a   Kasugai, Tsutomu ^a   Sawai, Yuka ^a   Koizumi, Masahiko ^a   Nose, Takayuki ^a   Koyama, Hiroki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Breast cancer; Breast conserving treatment; Local recurrence; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN;

ADJUVANT THERAPY; BREAST TUMOR; FEMALE; HUMAN; PAGET NIPPLE DISEASE; PATHOLOGY; REVIEW; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EPIRUBICIN; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL;

EID: 0036048947     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967542     Document Type: Review

References (28)

1. Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685, 1998. (Pubitemid 28363030)
2. Calais G, Berger C, Descamps P, et al: Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74:1283-1288, 1994. (Pubitemid 24301781)
3. Schwartz GF, Birchansky CA, Komaraicky LT, et al: Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73:362-369, 1994. (Pubitemid 24030615)
4. Veronesi U, Bonadonna G, Zurrida S, et al: Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 222:612-618, 1995.
5. Touboul E, Lefranc JP, Blondon J, et al: Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced noninflammatory breast cancer. Radiother Oncol 42:219-229, 1997. (Pubitemid 27179674)
6. Merajver SD, Weber BL, Cody R, et al: Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. J Clin Oncol 15:2873-2881, 1997. (Pubitemid 27330015)
7. Bonadonna G, Valagussa P, Brambilla C, et al: Primary chemotherapy in operable breast cancer: Eightyear experience at the Milan Cancer Institute. J Clin Oncol 16:93-100, 1998. (Pubitemid 28041584)
8. Danforth DN Jr, Zujewski J, O'Shaughnessy J, et al: Selection of local therapy after neoadjuvant chemotherapy in patients with stage III A, B breast cancer. Ann Surg Oncol 5:150-158, 1998. (Pubitemid 29071284)
9. Mauriac L, MacGrogan G, Avril A, et al: Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Ann Oncol 10:47-52, 1999. (Pubitemid 29090591)
10. Kuerer HM, Newman LA, Smith TL, et al: Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460-469, 1999. (Pubitemid 29075229)
11. Bellino R, Cortese P, Danese S, et al: Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. Anticancer Res 20:4825-4828, 2000. (Pubitemid 32127737)
12. Gradishar WJ: Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer. Oncol 11(supp 8):15-18, 1997. (Pubitemid 27357871)
13. Scholl SM, Fourquet A, Asselain B, et al: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomized trial: S6. Eur J Cancer 30 A: 645-652, 1994. (Pubitemid 24164252)
14. Makris A, Powles TJ, Ashley SE, et al: A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 9:1179-1184, 1998. (Pubitemid 28552806)
15. Noguchi S, Koyama H, Kasugai T, et al: A case-control study on risk factors for local recurrences or distant metastases in breast cancer patients treated with breast-conserving surgery. Oncol 54:468-474, 1997. (Pubitemid 27470257)
16. Hunt KK, Buzdar AU: Breast conservation and tumor down-staging. In: Singletary S, ed. Breast Cancer. New York: Springer-Verlag, pp196-205, 1998.
17. El-Didi MH, Moneer MM, Khaled HM, et al: Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management. Surg Today 30:249-254, 2000. (Pubitemid 30187218)
18. Huber S, Wagner M, Zuna I, et al: Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy. Anticancer Res 20:553-558, 2000. (Pubitemid 30189720)
19. Esserman L, Hylton N, Yassa L, et al: Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17:110-119, 1999. (Pubitemid 29022384)
20. Akashi-Tanaka S, Fukutomi T, Miyakawa K, et al: Contrast-enhanced computed tomography for diagnosing the intraductal component and small invasive foci of breast cancer. Breast Cancer 8:10-15, 2001.
21. Singletary SE, Dhingra K, Yu DH: New strategies in locally advanced breast cancer. Cancer Treat Res 90:253-271, 1997.
22. Ellis P, Smith I, Ashley S, et al: Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. J Clin Oncol 16:107-114, 1998. (Pubitemid 28041586)
23. Kuerer HM, Hunt KK, Newman LA et al: Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg 190:350-363, 2000. (Pubitemid 30118396)
24. Nishimura R, Koyama H, Kasumi F et al: A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgery. Oncol 55:391-399, 1998. (Pubitemid 28396049)
25. Kuerer HM, Sahin AA, Hunt KK et al: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230:72-78, 1999. (Pubitemid 30190367)
26. Cox CE, Haddad F, Bass S et al: Lymphatic mapping in the treatment of breast cancer. Oncology 12:1283-1298, 1998.
27. Motomura K, Inaji H, Komoike Y, et al: Gamma probe and ultrasonographically-guided fine needle aspiration biopsy of sentinel lymph node in breast cancer patients. Eur J Surg Oncol 27:141-145, 2001. (Pubitemid 32621724)
28. Powles TJ, Hickish TF, Makris HA, et al: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13:547-552, 1995.